Help me understand what LL is saying here? She seems to be saying she could do what NWBO does but that's not going to work. Then she says what does works is personalized. Very confusing:
"And we give it. We either license it out or start your own little startup. Here at Stanford, it’s a very start-up environment. It depends on your goals. If your goal is to have a startup and then have a pharmaceutical company buy you out or get an IPO, you could do that. We could do the same thing Northwest Bio, Tocagen, Selbach, or any of these companies that have already done trials do.
But at the end of the day, it doesn’t really cure GBM unless there’s something a little bit broader. I guess in my heart of hearts, I think what’s going to cure the disease is going to be personalized. It’s going to be something that comes from the person or the tumor itself and I’m not sure how that can be patented other than the idea and the process by which that’s done."
-LL
Market Data 
Markets 
AI
